- Trials with a EudraCT protocol (19)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
19 result(s) found for: Community psychiatry.
Displaying page 1 of 1.
EudraCT Number: 2021-006510-36 | Sponsor Protocol Number: NL79264.091.21 | Start Date*: 2021-12-21 | |||||||||||
Sponsor Name:Radboudumc | |||||||||||||
Full Title: Exploring the Pharmacomicrobiomics of Depression | |||||||||||||
Medical condition: Major Depressive Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-000240-26 | Sponsor Protocol Number: CBD_ADD_IN | Start Date*: 2013-10-29 | |||||||||||
Sponsor Name:King's College London [...] | |||||||||||||
Full Title: Cannabidiol as an add-on therapy in treatment-refractory psychotic disorders | |||||||||||||
Medical condition: Schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001548-23 | Sponsor Protocol Number: 20124444 | Start Date*: 2012-11-28 |
Sponsor Name:ParnassiaBavoGroup | ||
Full Title: An open label study with objective sleepregistration on the effects of Doxazosin as treatment for PTSD, especially for sleep disturbance | ||
Medical condition: Posttraumatic stress disorder | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-004602-17 | Sponsor Protocol Number: 031-201-00186 | Start Date*: 2018-03-12 | |||||||||||
Sponsor Name:Otsuka Pharmaceutical | |||||||||||||
Full Title: A Multicentre, 8-week, Single-arm, Open-label, Pragmatic Trial to Explore Acceptance and Performance of Using a Digital Medicine System with Healthcare Professionals and Adult Subjects with Schizo... | |||||||||||||
Medical condition: Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-002787-32 | Sponsor Protocol Number: RG_19-172 | Start Date*: 2020-11-16 |
Sponsor Name:University of Birmingham | ||
Full Title: Antidepressant for the prevention of DEPression following first episode Psychosis trial | ||
Medical condition: Patients with First Episode Psychosis. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2022-001244-15 | Sponsor Protocol Number: D22-P006 | Start Date*: 2023-01-12 |
Sponsor Name:GHU Paris Psychiatrie et Neurosciences | ||
Full Title: Efficiency of a composite personalised care on functional outcome in early psychosis: A Prospective Randomised Controlled Trial - PsyCARE_Trial | ||
Medical condition: early psychosis | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2011-005218-13 | Sponsor Protocol Number: 2167SR | Start Date*: 2012-04-23 | ||||||||||||||||
Sponsor Name:Kings College London [...] | ||||||||||||||||||
Full Title: Rationalisation of antipsychotic drug use in older people, using [18F]-Fallypride PET | ||||||||||||||||||
Medical condition: Alzheimer's Disease and schizophrenia like illness | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-002584-25 | Sponsor Protocol Number: 10/46/01 | Start Date*: 2014-11-06 | |||||||||||
Sponsor Name:King's College London [...] | |||||||||||||
Full Title: Naltrexone Enhanced Addiction Treatment (NEAT): A randomised controlled trial of the clinical and cost-effectiveness of extended-release naltrexone and oral naltrexone. | |||||||||||||
Medical condition: Opiate addiction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000942-21 | Sponsor Protocol Number: AIMS-2-CT1 | Start Date*: 2019-07-24 | |||||||||||||||||||||
Sponsor Name:Celso Arango | |||||||||||||||||||||||
Full Title: A Phase II Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Arbaclofen Administered for the Treatment of Social Function in Children and Adolescents w... | |||||||||||||||||||||||
Medical condition: Autism Spectrum Disorder | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003306-40 | Sponsor Protocol Number: E2006-G000-202 | Start Date*: 2018-02-27 |
Sponsor Name:Eisai Ltd. | ||
Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study with Open-Label Extension Phase of the Efficacy and Safety of Lemborexant in Subjects with Irregular Sleep-Wake Rhy... | ||
Medical condition: Irregular Sleep-Wake Rhythm Disorder in Subjects with Mild to Moderate Alzheimer’s Disease Dementia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-002237-11 | Sponsor Protocol Number: ARC | Start Date*: 2012-12-17 |
Sponsor Name:King's College London [...] | ||
Full Title: Effectiveness of Adaptive Opioid Agonist Maintenance Pharmacotherapy and Behavioural Therapy for Opioid Use Disorder. | ||
Medical condition: Opiate dependency disorder | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-001952-12 | Sponsor Protocol Number: CAFQ056B2279 | Start Date*: 2011-11-03 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: An open-label study to evaluate the long-term safety, tolerability and efficacy of AFQ056 in adult patients with Fragile X Syndrome | |||||||||||||
Medical condition: Fragile X Syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) FR (Completed) GB (Prematurely Ended) DK (Prematurely Ended) ES (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-022638-96 | Sponsor Protocol Number: CAFQ056B2214 | Start Date*: 2011-06-15 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of AFQ056 in adolescent patients with Fragile X Syndrome | |||||||||||||
Medical condition: Fragile X Syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) SE (Completed) FR (Completed) DK (Completed) DE (Completed) ES (Completed) Outside EU/EEA IT (Completed) BE (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-003219-22 | Sponsor Protocol Number: LMS/SF/UH/0018 | Start Date*: 2014-01-27 | |||||||||||
Sponsor Name:Hertfordshire Partnership University NHS Foundation Trust [...] | |||||||||||||
Full Title: A randomised controlled feasibility trial comparing clinical and cost effectiveness of cognitive behavioural therapy (CBT) and selective serotonin reuptake inhibitors (SSRI) and their combination i... | |||||||||||||
Medical condition: Obsessive Compulsive Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-001711-31 | Sponsor Protocol Number: D1050238 | Start Date*: 2012-02-29 | |||||||||||
Sponsor Name:Sunovion Pharmaceuticals Inc. | |||||||||||||
Full Title: A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance treatment of subjects with schizophrenia | |||||||||||||
Medical condition: Schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-003850-26 | Sponsor Protocol Number: 31-11-284 | Start Date*: 2012-01-30 | |||||||||||
Sponsor Name:Otsuka Pharmaceutical Development & Commercialization, Inc. | |||||||||||||
Full Title: A Multicenter, Open-label Study to Assess Hospitalization Rates in Adult Subjects with Schizophrenia Treated Prospectively for 6 Months with Aripiprazole IM Depot Compared with 6-month Retrospectiv... | |||||||||||||
Medical condition: Schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) BE (Prematurely Ended) ES (Prematurely Ended) DE (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-003136-23 | Sponsor Protocol Number: CRO1990 | Start Date*: 2012-11-27 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:Imperial College London | ||||||||||||||||||||||||||||||||||||||
Full Title: Lamotrigine And Borderline Personality Disorder: Investigating Long-Term Effectiveness | ||||||||||||||||||||||||||||||||||||||
Medical condition: Borderline Personality Disorder | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-002430-36 | Sponsor Protocol Number: AntibioTICS | Start Date*: 2012-07-02 | |||||||||||
Sponsor Name:AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA | |||||||||||||
Full Title: Multicentre, randomised, double-blinded, placebo-controlled trial of efficacy of amoxicilline/clavulanic acid in patients affected by tic disorder colonized by GAS. No-proft stidy. | |||||||||||||
Medical condition: Chronic tic disorder | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) ES (Ongoing) NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002764-27 | Sponsor Protocol Number: NILVAD2012 | Start Date*: 2013-02-04 | |||||||||||
Sponsor Name:St James's Hospital | |||||||||||||
Full Title: A European multicenre double-blind placebo controlled phase III trial of nilvadipine in mild to moderate Alzheimer's disease. | |||||||||||||
Medical condition: Mild to Moderate Alzheimer's Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) IE (Completed) SE (Completed) HU (Completed) GR (Completed) NL (Completed) IT (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
